Angiogenesis in malignant lymphoma, Current Opinion in Oncology, vol.17, issue.6, pp.611-617, 2005. ,
DOI : 10.1097/01.cco.0000181404.83084.b5
Vascular patterns in reactive lymphoid tissue and in non-Hodgkin's lymphoma, British Journal of Cancer, vol.88, issue.4, pp.553-562, 2003. ,
DOI : 10.1038/sj.bjc.6600742
Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression, Laboratory Investigation, vol.103, issue.11, pp.1512-1521, 2004. ,
DOI : 10.1038/labinvest.3700145
Complete response of relapsed angioimmunoblastic T-cell lymphoma following therapy with bevacizumab, Annals of Oncology, vol.19, issue.2, pp.396-403, 2008. ,
DOI : 10.1093/annonc/mdm579
Evaluation and management of angioimmunoblastic T-cell lymphoma: a review of current approaches and future strategies, Clin Adv Hematol Oncol, vol.6, pp.899-909, 2008. ,
Complete remission in a patient with relapsed angioimmunoblastic T-cell lymphoma following treatment with bevacizumab, Leukemia, vol.32, issue.11, pp.1993-1998, 2005. ,
DOI : 10.1182/blood-2004-01-0226
Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications, Current Opinion in Hematology, vol.14, issue.4, pp.348-53, 2007. ,
DOI : 10.1097/MOH.0b013e328186ffbf
Bcl-2 Orchestrates a Cross-talk between Endothelial and Tumor Cells that Promotes Tumor Growth, Cancer Research, vol.67, issue.20, pp.9685-93, 2007. ,
DOI : 10.1158/0008-5472.CAN-07-1497
Endothelial cells expressing Bcl-2 promotes tumor metastasis by enhancing tumor angiogenesis, blood vessel leakiness and tumor invasion, Laboratory Investigation, vol.60, issue.7, pp.740-749, 2008. ,
DOI : 10.1016/j.bbrc.2005.12.201
Hypoxia-induced Bcl-2 expression in endothelial cells via p38 MAPK pathway, Biochemical and Biophysical Research Communications, vol.394, issue.4, pp.976-80, 2010. ,
DOI : 10.1016/j.bbrc.2010.03.102
Bcl-2 Protects Endothelial Cells against ??-Radiation via a Raf-MEK-ERK-Survivin Signaling Pathway That Is Independent of Cytochrome c Release, Cancer Research, vol.67, issue.3, pp.1193-202, 2007. ,
DOI : 10.1158/0008-5472.CAN-06-2265
G3139, an Anti-Bcl-2 Antisense Oligomer That Binds Heparin-Binding Growth Factors and Collagen I, Alters In vitro Endothelial Cell Growth and Tubular Morphogenesis, Clinical Cancer Research, vol.15, issue.8, pp.2797-807, 2009. ,
DOI : 10.1158/1078-0432.CCR-08-2610
Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours, Cardiovascular Research, vol.86, issue.1, pp.12-21, 2010. ,
DOI : 10.1093/cvr/cvp332
Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas, Acta Neuropathologica, vol.34, issue.2, pp.147-56, 2007. ,
DOI : 10.1007/s00401-007-0251-4
Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma, Croat Med J, vol.46, pp.417-439, 2005. ,
Endoglin (CD105) as a prognostic factor in head and neck squamous cell carcinoma, Virchows Archiv, vol.9, issue.6, pp.768-75, 2006. ,
DOI : 10.1007/s00428-006-0195-4
Endoglin (CD 105) is expressed on endothelial cells in the primary central nervous system lymphomas and correlates with survival, Journal of Neuro-Oncology, vol.17, issue.3, pp.249-56, 2007. ,
DOI : 10.1007/s11060-006-9281-3
WHO classification of tumours of hematopoietic and lymphoid tissues, 2008. ,
Angioimmunoblastic-Like T-Cell Non Hodgkin's Lymphoma: Outcome After Chemotherapy in 33 Patients and Review of the Literature, Leukemia & Lymphoma, vol.88, issue.1, pp.545-52, 1999. ,
DOI : 10.1111/j.1365-2141.1991.tb08114.x
Tumor Angiogenesis and Metastasis ??? Correlation in Invasive Breast Carcinoma, New England Journal of Medicine, vol.324, issue.1, pp.1-8, 1991. ,
DOI : 10.1056/NEJM199101033240101
Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours, European Journal of Cancer, vol.38, issue.12, pp.1564-79, 2002. ,
DOI : 10.1016/S0959-8049(02)00094-1
Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation, European Journal of Cancer, vol.32, issue.14, pp.2474-84, 1996. ,
DOI : 10.1016/S0959-8049(96)00379-6
Angiogenic mediators of the angiopoietin system are highly expressed by CD10-positive lymphoma cells in angioimmunoblastic T-cell lymphoma, British Journal of Haematology, vol.84, issue.5, pp.696-704, 2009. ,
DOI : 10.1111/j.1365-2141.2008.07534.x
A novel subset of T-helper cells: follicular T-helper cells and their markers, Haematologica, vol.95, issue.3, pp.356-364, 2010. ,
DOI : 10.3324/haematol.2009.019133
Marker Expression in Peripheral T-Cell Lymphoma: A Proposed Clinical-Pathologic Prognostic Score, Journal of Clinical Oncology, vol.24, issue.16, pp.2472-2481, 2006. ,
DOI : 10.1200/JCO.2005.03.6327
Bcl-xL Gene Expression Correlated with Lower Apoptotic Cell Numbers and Shorter Progression-Free Survival in PCFCL, Journal of Investigative Dermatology, vol.129, issue.7, pp.1703-1712, 2009. ,
DOI : 10.1038/jid.2008.430
Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance, British Journal of Dermatology, vol.90, issue.6, pp.1183-91, 2003. ,
DOI : 10.1046/j.1365-2133.2002.47329.x
Clinical role of Bcl-2, Bax, or p53 overexpression in peripheral T-cell lymphomas, Annals of Hematology, vol.69, issue.9, pp.575-81, 2006. ,
DOI : 10.1007/s00277-006-0127-z
Attenuation of retinal endothelial cell migration and capillary morphogenesis in the absence of bcl-2, AJP: Cell Physiology, vol.294, issue.6, pp.1521-1551, 2008. ,
DOI : 10.1152/ajpcell.90633.2007
Unidirectional crosstalk between Bcl-xL and Bcl-2 enhances the angiogenic phenotype of endothelial cells, Cell Death and Differentiation, vol.2, issue.9, pp.1657-66, 2007. ,
DOI : 10.1101/gad.252603
Induction, differentiation, and remodeling of blood vessels after transplantation of Bcl-2-transduced endothelial cells, Proceedings of the National Academy of Sciences, vol.102, issue.2, pp.425-455, 2005. ,
DOI : 10.1073/pnas.0408357102
Antiapoptotic Activities of Bcl-2 Correlate with Vascular Maturation and Transcriptional Modulation of Human Endothelial Cells, Endothelium, vol.26, issue.1-2, pp.59-71, 2008. ,
DOI : 10.1158/0008-5472.CAN-04-1437
Vascular Endothelial Growth Factor (VEGF)-Mediated Angiogenesis Is Associated with Enhanced Endothelial Cell Survival and Induction of Bcl-2 Expression, The American Journal of Pathology, vol.154, issue.2, pp.375-84, 1999. ,
DOI : 10.1016/S0002-9440(10)65284-4
Up-Regulation of BCL2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth, Cancer Res, vol.61, pp.2183-2191, 2001. ,
Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis, Cancer Res, vol.59, pp.856-61, 1999. ,
Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer, The Prostate, vol.97, issue.4, pp.268-75, 2002. ,
DOI : 10.1002/pros.10083
CD105 is important for angiogenesis: evidence and potential applications, The FASEB Journal, vol.17, issue.9, pp.984-92, 2003. ,
DOI : 10.1096/fj.02-0634rev
Angiogenesis in life, disease and medicine, Nature, vol.Teill II, issue.7070, pp.932-938, 2005. ,
DOI : 10.1038/nature04478
Stromal Gene Signatures in Large-B-Cell Lymphomas, New England Journal of Medicine, vol.359, issue.22, pp.2313-2336, 2008. ,
DOI : 10.1056/NEJMoa0802885